Drugplain

Influenzinum 9 [hp_C]/4g

Influenzinum 9C · PELLET · Homeocare Laboratories

1 Recall on Record
Plain English

Influenzinum is a pellet containing influenzinum 9c at 9 [hp_C]/4g, taken sublingual. Manufactured by Homeocare Laboratories.

Key Facts

Brand Name
Influenzinum
Generic Name
Influenzinum 9C
NDC Code (Product)
61727-341
Manufacturer
Homeocare Laboratories
Strength
9 [hp_C]/4g
Dosage Form
PELLET
Route
SUBLINGUAL
Marketing Status
Marketing Start
10/31/2012

Recall History

1 Recall on Record
Class II05/13/2022

Washington Homeopathic Products, Inc.

cGMP deviations

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

angioedema1 reports
aortic dilatation1 reports
back pain1 reports
blood pressure increased1 reports
cerebrovascular accident1 reports
contusion1 reports
dysphagia1 reports
dysphonia1 reports
eyelid oedema1 reports
face oedema1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Relieves after effects of flu or flu-like symptoms * See symptoms on front panel.

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Frequently Asked Questions

What is Influenzinum used for?

Influenzinum contains Influenzinum 9C. It is a pellet taken sublingual. Consult your doctor for specific uses.

Is Influenzinum a controlled substance?

Influenzinum is not classified as a controlled substance by the DEA.

What is the generic name for Influenzinum?

The generic name for Influenzinum is Influenzinum 9C. There are no other listed brand versions of Influenzinum 9C.

What is the NDC code for Influenzinum 9 [hp_C]/4g?

The NDC (National Drug Code) for Influenzinum 9 [hp_C]/4g is 61727-341, listed by Homeocare Laboratories.

Product NDC

61727-341

Package NDC

61727-341-21

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)